EPO Patents = 1

Forward Citations = 3

Loading Chart...

11 inventors (with patents filed for the assignee):

Ke Yu (3 out of 13 patents)

Xuesai Zhang (3 out of 4 patents)

Qing Lin (3 out of 3 patents)

4. Qingrou Li (3 out of 4 patents)

5. Tao Meng (2 out of 10 patents)

6. Jingkang Shen (2 out of 19 patents)

7. Lanping Ma (2 out of 7 patents)

8. Chaohong Hu (2 out of 2 patents)

9. Hu Li (1 out of 10 patents)

10. Wenchao Liu (1 out of 2 patents)

11. Zhenyu Dai (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12290505 - Tissue factor-targeted antibody-drug conjugate (2025-05-06),

2. 12103978 - Methods and materials for treating cancer (2024-10-01),

3. 11534495 - Tissue factor-targeted antibody-drug conjugate (2022-12-27),

4. 10792370 - Antibody-drug conjugate (2020-10-06),

5. 10676537 - Antibody targeted to tissue factor, preparation method therefor, and use thereof (2020-06-09),

Company Overview

Shanghai Miracogen Inc. is a biotechnology company focused on the development and commercialization of innovative immuno-oncology therapies. Established in Shanghai, the company leverages cutting-edge technology to create novel treatments aimed at enhancing the immune response against various forms of cancer. With a strong commitment to research and development, Miracogen aims to improve patient outcomes through targeted therapies that harness the body's immune system. Their pipeline includes several promising candidates currently in clinical trials, addressing unmet medical needs in oncology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#455 in Shanghai

#5,271 in China

Shanghai, China

Shanghai Miracogen Inc

Forward Citations = 3

11 inventors:

Ke Yu (3 out of 13 patents)

Xuesai Zhang (3 out of 4 patents)

Qing Lin (3 out of 3 patents)

4. Qingrou Li (3 out of 4 patents)

5. Tao Meng (2 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shanghai Miracogen Inc. Retrieved from https://idiyas.com/company/shanghai-miracogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]